Intranasal TXA for Anterior Epistaxis in the Emergency Department
Status:
Suspended
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy of and patient satisfaction with the
use of intranasal tranexamic acid (TXA) for anterior nosebleeds in the emergency department
(ED).